Phytochemical and Pharmacological Insights into Millingtonia hortensis: A Comprehensive Review

Millingtonia hortensis, a flowering plant of the Bignoniaceae family, has garnered significant interest in both traditional and modern medicine due to its rich phytochemical profile and diverse pharmacological activities. This review aims to provide a comprehensive consolidation of the current scientific literature on Millingtonia hortensis, emphasizing its phytochemistry, traditional uses, and pharmacological properties. The plant contains various bioactive compounds such as alkaloids, flavonoids, glycosides, and terpenoids, which have been linked to therapeutic effects including anti-inflammatory, antimicrobial, antioxidant, anticancer, anti-asthmatic, neuroprotective, and cardioprotective properties. Traditionally, Millingtonia hortensis has been used in several cultures, particularly in Ayurvedic and Siddha medicine, to treat respiratory ailments, infectious diseases, and inflammatory conditions. The methodologies used in studying this plant involve phytochemical analyses and in vitro and in vivo pharmacological assessments that demonstrate its therapeutic potential. However, while numerous studies highlight its biological activities, the exact mechanisms of action, clinical efficacy, and safety profiles are not fully elucidated. Research gaps also exist in understanding its potential toxicity and interactions with other therapeutic agents. This review highlights the need for future research to focus on developing standardized herbal formulations, investigating synergistic effects with other traditional remedies, and conducting extensive toxicity and clinical studies. By addressing these gaps, Millingtonia hortensis could be established as a viable therapeutic agent in contemporary medicine. Its contribution to natural medicine reflects the growing interest in plant-based treatments and underscores the importance of integrating traditional knowledge with modern scientific research. Practical and social implications of this study include the potential development of affordable, accessible plant-based therapies that could benefit public health globally, particularly in regions where traditional medicine is still a primary healthcare approach.